Nanoparticles: Clinical Trials

9 trials of Nanoparticles, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 completed, 2 unknown, 1 active not recruiting, 1 suspended. 4 Not applicable, 3 Phase 1, 2 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable4Completed 2, Active not recruiting 1, Unknown 1
Phase 13Completed 2, Suspended 1
Phase 22Completed 1, Unknown 1

Follow Nanoparticles: new trials by email Literature Review of Nanoparticles trials Research Report on Nanoparticles

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Novel RNA-lipid Particle (RNA-LP) Vaccine for Anti-PD-1 Antibody Therapy Sensitization
Autologous total tumor mRNA loaded DOTAP liposome vaccine - Melanoma, Soft Tissue Sarcoma
Phase 1SuspendedUniversity of Florida182026-03-172026-09-17
Effect of Different NanoScaffolds on Pulp Regeneration in Non-Vital Immature Permanent Teeth (Randomized Clinical Trial)
Platelet rich fibrin - Necrotic Immature Permanent Incisors
Not applicableActive not recruitingTanta University402025-07-282025-08-13
Post-operative Sensitivity in Resin Composites
Group A(Nano-fortified Adhesive), Group B(Adhesive without nanoparticles) - Caries,Dental, Sensitivity, Tooth
Not applicableCompletedPakistan Institute of Medical Sciences602023-05-152024-02-06
Trueness and Dimensional Deviation of 3D Printed Nanocomposite Maxillary Denture Base Resin (In Vivo Study)
nanoparticles - Denture Hyperplasia
Not applicableCompletedTanta University242023-02-152025-05-06
Nab-paclitaxel/Rituximab-coated Nanoparticle AR160 in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma, LS1681 Trial
Laboratory Biomarker Analysis, Nab-paclitaxel/Rituximab-coated Nanoparticle AR160, Pharmacological Study - Recurrent Aggressive Non-Hodgkin Lymphoma, Recurrent B-Cell Non-Hodgkin Lymphoma
Phase 1CompletedMayo Clinic92019-04-252023-06-15
Effect of the Incoportation of Copper and Zinc Nanoparticles Into Dental Adhesives
Metal nanoparticles ( O Zn and Cu), Dental Adhesive pure - Caries, Dental
Not applicableUnknownUniversity of Chile352018-12-012018-08-17
A Phase I SAD and MAD Clinical Trial of CNM-Au8 in Healthy Male and Female Volunteers
CNM-Au8, Placebo - Healthy Volunteers - Male and Female
Phase 1CompletedClene Nanomedicine862015-04-012019-06-03
Fluor Varnish With Silver Nanoparticles for Dental Remineralization in Patients With Trisomy 21
Fluor varnish, Fluor varnish with nanoparticles - Down Syndrome
Phase 2UnknownUniversidad Autonoma de San Luis Potosí202012-09-012014-03-07
Induction Chemotherapy With ACF Followed by Chemoradiation Therapy for Adv. Head & Neck Cancer
paclitaxel albumin-stabilized nanoparticle formulation, Cisplatin, Fluorouracil - Head and Neck Neoplasms
Phase 2CompletedWashington University School of Medicine302012-08-092020-10-01

Conditions studied

Dental Caries (2)  ·  Dentin Sensitivity (1)  ·  Down Syndrome (1)  ·  Head and Neck Neoplasms (1)  ·  Leukemia, Lymphocytic, Chronic, B-Cell (1)  ·  Lymphoma, B-Cell (1)  ·  Melanoma (1)  ·  Sarcoma (1)

Sponsors

Tanta University (2)  ·  Clene Nanomedicine (1)  ·  Mayo Clinic (1)  ·  Pakistan Institute of Medical Sciences (1)  ·  Universidad Autonoma de San Luis Potosí (1)  ·  University of Chile (1)  ·  University of Florida (1)  ·  Washington University School of Medicine (1)

Countries

United States (3)  ·  Egypt (2)  ·  Chile (1)  ·  Mexico (1)  ·  Netherlands (1)  ·  Pakistan (1)

Top investigators

Douglas Adkins, M.D. (1)  ·  Eman Mohamed Shakal, prof (1)  ·  G.J. Groeneveld, MD, PhD (1)  ·  Houda Amin Rashad, prof (1)  ·  Leighton Elliott, MD (1)  ·  Nehal Amir, BDS (1)  ·  Thomas M Habermann (1)

Results publications

PMID 28797458, PMID 31147146, PMID 39267015

NIH funding

P50CA097274 (1)